Marino Garcia
Director · AgomAb Therapeutics NV
IndividualSelling only18 10b5-1 trades
- 2025
- Sep 15, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Marino Garcia files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Simrat Randhawa - $15.00M in DNTH purchases and sales in the last 12 months
- Ryan Savitz - $14.29M in DNTH purchases and sales in the last 12 months
- Edward Carr - $5.59M in DNTH purchases and sales in the last 12 months
- Adam M. Veness - $4.63M in DNTH purchases and sales in the last 12 months
- Paula Soteropoulos - $2.25M in DNTH purchases and sales in the last 12 months
- Anne McGeorge - $845K in DNTH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Marino Garcia?
Marino Garcia is a corporate insider, tracked as Director of AgomAb Therapeutics NV (AGMB). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Marino Garcia submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Marino Garcia been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($27.96M) across all tracked filings.
